Breaking News

SNBL USA Names European BD Director

September 10, 2013

Kelly responsible for driving growth in the region

Janet Kelly, MSc, has been appointed director of business development for the European region at SNBL USA. Ms. Kelly will be responsible for driving growth of the European business, including fostering relationships with new and current customers.
Ms. Kelly joins the company from CJS Scientific, Ltd., where she served as director and consultant to the pharmaceutical and agrochemical industries in the fields of nonclinical development, toxicology, translational medicine and dossier preparation. Prior to CJS she held several positions at Covance, including director of operations at Covance R&D (Shanghai, China), associate director of business development, head of operations and head of toxicology study direction.
“With more than 26 years of industry experience, Janet has held a number of key posts with progressively responsible roles in study direction, business development and operations,” said Mark Crane, SNBL USA vice president of business development. “Her preclinical market understanding, experiences and direct knowledge of the rapidly changing European market dynamics will be of great value to SNBL USA and all its customers. I am excited to have Janet on our team.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.